What is triple-negative breast cancer and how is it identified? How can triple-negative breast cancers escape the immune system? And how can determining whether circulating tumor DNA in blood samples be used to predict metastatic breast cancer or treatment resistance in patients with aggressive disease?
BCRF investigator since 2007, Dr. Hope Rugo answers these questions and many more on the latest episode of Investigating Breast Cancer.
Developing Personalized Risk Prediction with Dr. Mark Robson
Unraveling Metastatic Breast Cancer, with Dr. Martine Piccart
Young women and breast cancer, with Dr. Ann Partridge
BCRF Symposium & Awards Luncheon: Live from New York City
Mapping and understanding brain metastasis in breast cancer, with Dr. Priscilla Brastianos
The De-Escalation of Therapy, with Dr. Eric Winer
What Should I Eat? We asked Dr. Walter Willett
Improving breast cancer diagnosis and care in remote and low resource communities, with Dr. Lawrence Shulman
Focusing on early treatment, with Dr. Luca Gianni
Evaluating natural cancer treatments with Dr. Susan Horwitz
Inspiration and insight from breast cancer patients, with Dr. Gabriel Hortobagyi
New strategies to prevent and treat metastatic breast cancer, with Dr. Sofia Merajver
Avoiding chemotherapy, with Dr. Joseph Sparano
How does cancer grow?, with Dr. Ben Ho Park
Making a difference in patients' lives, with Dr. Hedvig Hricak
Studying breast cancer at the single cell level, with Dr. Michael Wigler
Managing the stress of cancer treatments, with Dr. Annette Stanton
Attacking cancer's weaknesses, with Dr. Alan Ashworth
A Closer Look at Metastatic Breast Cancer with Dr. Robert Schneider
How randomized clinical trials can inform breast cancer prevention strategies, with Dr. Jack Cuzick
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
2 Peas in A Pod
LMU An introduction to Bohmian Mechanics